EcoR1 Capital, LLC - 06 Nov 2024 Form 4 Insider Report for Tango Therapeutics, Inc. (TNGX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Nov 2024, 19:24:48 UTC
Prior SEC filing
16 Aug 2024
Next SEC filing
26 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Oleg Nodelman, Manager of EcoR1 Capital, LLC

Key filing fact

EcoR1 Capital, LLC filed Form 4 for Tango Therapeutics, Inc. (TNGX) on 08 Nov 2024.

Key facts

  • This page summarizes EcoR1 Capital, LLC's Form 4 filing for Tango Therapeutics, Inc. (TNGX).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Nov 2024, 19:24.

Change

  • Previous filing in this sequence was filed on 16 Aug 2024.
  • Current net transaction value: -$8,435,743.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TNGX transaction

Common Stock

Sale

Transaction value
$4,896,023
Shares
-1,494,558
Change %
-11%
Price
$3.28
Shares after
11,836,178
Date
06 Nov 2024
Ownership
See Note
Footnotes
F1, F2, F3
TNGX transaction

Common Stock

Sale

Transaction value
$205,113
Shares
-62,318
Change %
-0.53%
Price
$3.29
Shares after
11,773,860
Date
07 Nov 2024
Ownership
See Note
Footnotes
F1, F4, F5
TNGX transaction

Common Stock

Sale

Transaction value
$3,334,607
Shares
-1,143,124
Change %
-9.7%
Price
$2.92
Shares after
10,630,736
Date
07 Nov 2024
Ownership
See Note
Footnotes
F1, F6, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

EcoR1 Capital, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 7 footnotes

Footnote F1

The filers are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Qualified Fund and Mr. Nodelman. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim ownership of such securities except to the extent of their respective pecuniary interests therein.

Footnote F2

Qualified Fund sold 1,406,529 of the shares sold in this transaction.

Footnote F3

After this transaction, Qualified Fund held 11,156,852 shares of Issuer's Common Stock.

Footnote F4

Qualified Fund sold 58,647 of the shares sold in this transaction.

Footnote F5

After this transaction, Qualified Fund held 11,098,205 shares of Issuer's Common Stock.

Footnote F6

Qualified Fund sold 1,075,794 of the shares sold in this transaction.

Footnote F7

After this transaction, Qualified Fund held 10,022,411 shares of Issuer's Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .